Assessing the Prevalence of Metabolic Syndrome and its Relationship with Ischemic Heart Disease (IHD) in Patients Referring to the Hospitals of Hamedan University of Medical Sciences

Metabolic syndrome (M.S.) is a common health problem in the world. Consisting of multiple interrelated risk factors, M.S. increases the risk of atherosclerotic cardiovascular disease by 1.5-3 times, and raises the risk for type 2 diabetes as much as 3-5 times. It affects over 26percent of adults. Patients with M.S are known to be at high risk for heart diseases. The aim of this study was to assess the prevalence of metabolic syndrome and find out about the relationship of this syndrome with coronary heart disease in patients who referred to the Heart Center of Hamedan University in 1387 (H.SH). A cross sectional study has been carried out on 1064 patients. We examined all the C.H.D patients (a total of 514) as well as 550 patients without CHD disease. The patients referred to the Heart Center over a period of three months. The patients with three or more of the following symptoms (IDF criteria) were considered to have Metabolic Syndrome: abdominal obesity (waist >102 cm for men; >88 cm for women),increased triglycerides (>150 mg/dl); low HDL-C (<40 mg/dl in men; <50 mg/dl in women), elevated blood pressure >=130/>=85 mmHg, and a raised fasting glucose (>=110 mg/dl). We have found significant differences between M.S. and I.H.D. The prevalence of M.S. was rated at 32.5 in patients and 21.3 in the others.. Men comprised 53.7% and women 46.3% of the patients with M.S., 13.6% of who were smokers. The findings of this study indicate that the rate of Hypertriglyceridemia was equal to or over 150 mg/dl in 39.1% of the subjects. The prevalence of M.S. in the sample of I.H.D patients was very high. Also, the correlation between M.S and other risk factors was very significant. As a matter of fact, it can be concluded that those patients with M.S. are at the high risk of being affected by cardiovascular disorders.